Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 71

    1.

    3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans.

    Zanetti KA, Haznadar M, Welsh JA, Robles AI, Ryan BM, McClary AC, Bowman ED, Goodman JE, Bernig T, Chanock SJ, Harris CC.

    Cancer Res. 2012 Mar 15;72(6):1467-77. Epub 2012 Jan 26.

    PMID:
    22282660
    [PubMed - indexed for MEDLINE]
    2.

    Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.

    Chang LY, Lin YC, Mahalingam J, Huang CT, Chen TW, Kang CW, Peng HM, Chu YY, Chiang JM, Dutta A, Day YJ, Chen TC, Yeh CT, Lin CY.

    Cancer Res. 2012 Mar 1;72(5):1092-102. Epub 2012 Jan 26.

    PMID:
    22282655
    [PubMed - indexed for MEDLINE]
    3.

    Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.

    Zaytseva YY, Rychahou PG, Gulhati P, Elliott VA, Mustain WC, O'Connor K, Morris AJ, Sunkara M, Weiss HL, Lee EY, Evers BM.

    Cancer Res. 2012 Mar 15;72(6):1504-17. Epub 2012 Jan 19.

    PMID:
    22266115
    [PubMed - indexed for MEDLINE]
    4.

    Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.

    Yang H, Higgins B, Kolinsky K, Packman K, Bradley WD, Lee RJ, Schostack K, Simcox ME, Kopetz S, Heimbrook D, Lestini B, Bollag G, Su F.

    Cancer Res. 2012 Feb 1;72(3):779-89. Epub 2011 Dec 16.

    PMID:
    22180495
    [PubMed - indexed for MEDLINE]
    5.

    Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells.

    Zhou Y, Tozzi F, Chen J, Fan F, Xia L, Wang J, Gao G, Zhang A, Xia X, Brasher H, Widger W, Ellis LM, Weihua Z.

    Cancer Res. 2012 Jan 1;72(1):304-14. Epub 2011 Nov 14.

    PMID:
    22084398
    [PubMed - indexed for MEDLINE]
    6.

    Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer.

    Bertini I, Cacciatore S, Jensen BV, Schou JV, Johansen JS, Kruhøffer M, Luchinat C, Nielsen DL, Turano P.

    Cancer Res. 2012 Jan 1;72(1):356-64. Epub 2011 Nov 11.

    PMID:
    22080567
    [PubMed - indexed for MEDLINE]
    7.

    Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasis.

    Maddalena F, Laudiero G, Piscazzi A, Secondo A, Scorziello A, Lombardi V, Matassa DS, Fersini A, Neri V, Esposito F, Landriscina M.

    Cancer Res. 2011 Dec 15;71(24):7659-69. Epub 2011 Nov 3.

    PMID:
    22052463
    [PubMed - indexed for MEDLINE]
    8.

    PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis.

    Bhalla K, Hwang BJ, Dewi RE, Ou L, Twaddel W, Fang HB, Vafai SB, Vazquez F, Puigserver P, Boros L, Girnun GD.

    Cancer Res. 2011 Nov 1;71(21):6888-98. Epub 2011 Sep 13.

    PMID:
    21914785
    [PubMed - indexed for MEDLINE]
    9.

    Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3.

    Liu F, Liu Q, Yang D, Bollag WB, Robertson K, Wu P, Liu K.

    Cancer Res. 2011 Nov 1;71(21):6807-16. Epub 2011 Sep 12.

    PMID:
    21911457
    [PubMed - indexed for MEDLINE]
    10.

    The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts high risk of colon cancer.

    Fellerhoff B, Gu S, Laumbacher B, Nerlich AG, Weiss EH, Glas J, Kopp R, Johnson JP, Wank R.

    Cancer Res. 2011 Dec 1;71(23):7145-54. Epub 2011 Oct 28.

    PMID:
    22037870
    [PubMed - indexed for MEDLINE]
    11.

    Enhancement of TGF-β signaling responses by the E3 ubiquitin ligase Arkadia provides tumor suppression in colorectal cancer.

    Sharma V, Antonacopoulou AG, Tanaka S, Panoutsopoulos AA, Bravou V, Kalofonos HP, Episkopou V.

    Cancer Res. 2011 Oct 15;71(20):6438-49.

    PMID:
    21998011
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    IRF-1 expression is essential for natural killer cells to suppress metastasis.

    Ksienzyk A, Neumann B, Nandakumar R, Finsterbusch K, Grashoff M, Zawatzky R, Bernhardt G, Hauser H, Kröger A.

    Cancer Res. 2011 Oct 15;71(20):6410-8. Epub 2011 Sep 7.

    PMID:
    21900395
    [PubMed - indexed for MEDLINE]
    13.

    TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.

    Sommariva M, De Cecco L, De Cesare M, Sfondrini L, Ménard S, Melani C, Delia D, Zaffaroni N, Pratesi G, Uva V, Tagliabue E, Balsari A.

    Cancer Res. 2011 Oct 15;71(20):6382-90. Epub 2011 Aug 30.

    PMID:
    21878529
    [PubMed - indexed for MEDLINE]
    14.

    Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers.

    Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, Miyano S, Mori M.

    Cancer Res. 2011 Oct 15;71(20):6320-6. Epub 2011 Aug 23. Erratum in: Cancer Res. 2012 Feb 15;72(4):1039.

    PMID:
    21862635
    [PubMed - indexed for MEDLINE]
    15.

    ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression.

    Kim SH, Park YY, Kim SW, Lee JS, Wang D, DuBois RN.

    Cancer Res. 2011 Nov 15;71(22):7010-20. Epub 2011 Sep 21.

    PMID:
    21937683
    [PubMed - indexed for MEDLINE]
    16.

    STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.

    Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C, Lin J.

    Cancer Res. 2011 Dec 1;71(23):7226-37. Epub 2011 Sep 7.

    PMID:
    21900397
    [PubMed - indexed for MEDLINE]
    17.

    Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells.

    Mazumdar T, Devecchio J, Agyeman A, Shi T, Houghton JA.

    Cancer Res. 2011 Sep 1;71(17):5904-14. Epub 2011 Jul 11.

    PMID:
    21747117
    [PubMed - indexed for MEDLINE]
    18.

    Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy.

    Halama N, Michel S, Kloor M, Zoernig I, Benner A, Spille A, Pommerencke T, von Knebel DM, Folprecht G, Luber B, Feyen N, Martens UM, Beckhove P, Gnjatic S, Schirmacher P, Herpel E, Weitz J, Grabe N, Jaeger D.

    Cancer Res. 2011 Sep 1;71(17):5670-7. Epub 2011 Aug 16.

    PMID:
    21846824
    [PubMed - indexed for MEDLINE]
    19.

    Systemic cancer therapy with a small molecule agonist of toll-like receptor 7 can be improved by circumventing TLR tolerance.

    Bourquin C, Hotz C, Noerenberg D, Voelkl A, Heidegger S, Roetzer LC, Storch B, Sandholzer N, Wurzenberger C, Anz D, Endres S.

    Cancer Res. 2011 Aug 1;71(15):5123-33. Epub 2011 Jun 22.

    PMID:
    21697281
    [PubMed - indexed for MEDLINE]
    20.

    MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma.

    Ibrahim AF, Weirauch U, Thomas M, Grünweller A, Hartmann RK, Aigner A.

    Cancer Res. 2011 Aug 1;71(15):5214-24. Epub 2011 Jun 20.

    PMID:
    21690566
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk